Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 170 entries
View as:

Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children

Phase: N/A Priority: Normal
NCT ID: NCT01584492 Org: User:
Start: 12/31/11 End: 02/28/13 Due: 02/28/14

Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT02500212 Org: User:
Start: 07/31/15 End: 06/30/16 Due: 06/30/17

The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT03558373 Org: User:
Start: 07/31/18 End: 02/26/20 Due: 02/26/21

Efficacy Study of the Product "CHF 1535" Versus Beclomethasone (BDP) and Free Combo in Asthmatic Children

Phase: N/A Priority: Normal
NCT ID: NCT01475032 Org: User:
Start: 09/30/11 End: 09/30/12 Due: 09/30/13

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Inhaled CHF6001

Phase: N/A Priority: Normal
NCT ID: NCT02386761 Org: User:
Start: 11/30/14 End: 05/31/15 Due: 05/31/16

Functional Respiratory Imaging Study

Phase: N/A Priority: Normal
NCT ID: NCT04876677 Org: User:
Start: 05/25/21 End: 01/03/22 Due: 01/03/23

Prospective Study on Asthma Control

Phase: N/A Priority: Normal
NCT ID: NCT01110460 Org: User:
Start: 01/31/09 End: 11/30/10 Due: 11/30/11

Investigate the Safety, Tolerability and Pharmacokinetics of CHF6523 in Healthy and in COPD Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04032535 Org: User:
Start: 07/24/19 End: 12/05/22 Due: 12/05/23

Formoterol-HFA 3-month Study in Chronic Obstructive Pulmonary Disease (COPD) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00972140 Org: User:
Start: 08/31/05 End: 10/31/06 Due: 10/31/07

Assessment of Efficacy, Safety and Dosing of Clevidipine in Pediatric Participants Undergoing Surgery (PIONEER)

Phase: N/A Priority: Normal
NCT ID: NCT01938547 Org: User:
Start: 03/17/14 End: 02/20/24 Due: 02/20/25

Evaluation of the Absolute Bioavailability and Mass Balance of CHF6001 (Tanimilast) in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04756960 Org: User:
Start: 03/10/21 End: 04/29/21 Due: 04/29/22

A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

Phase: N/A Priority: Normal
NCT ID: NCT04320342 Org: User:
Start: 04/28/22 End: 01/31/26 Due: 01/31/27

Phase II Study to Evaluate the Cardiac Safety of 2 Doses of CHF5993 Both Combined With CHF1535 BID Versus CHF1535 BID in Patients With Moderate to Severe COPD

Phase: N/A Priority: Normal
NCT ID: NCT01584505 Org: User:
Start: 04/30/12 End: 01/31/13 Due: 01/31/14

TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients With COPD

Phase: N/A Priority: Normal
NCT ID: NCT04671355 Org: User:
Start: 10/04/21 End: 02/18/22 Due: 02/18/23

Study Comparing Foster Efficacy Maintenance and Reliever Versus Foster Maintenance + Salbutamol Reliever in Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT00861926 Org: User:
Start: 03/31/09 End: 04/30/11 Due: 04/30/12

Effect of Cyclosporine Drug Interaction on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers. Drug-Drug Interaction 2 (DDI2) Study

Phase: N/A Priority: Normal
NCT ID: NCT06892756 Org: User:
Start: 03/18/25 End: 12/19/25 Due: 12/19/26

A Comparison Study Between Adolescents With Asthma and Adults With Asthma on How They Absorb, Metabolise and Eliminate CHF 6001

Phase: N/A Priority: Normal
NCT ID: NCT06900816 Org: User:
Start: 03/28/25 End: 11/30/25 Due: 11/30/26

Clinical Pharmacology of 35/4 NEXThaler® in Children 5-11 Years Old

Phase: N/A Priority: Normal
NCT ID: NCT02787967 Org: User:
Start: 08/31/16 End: 06/30/17 Due: 06/30/18

First In Human Study on Synthetic Surfactant CHF 5633 in Respiratory Distress Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01651637 Org: User:
Start: 10/31/12 End: 01/23/15 Due: 01/23/16

A Study to Evaluate the Efficacy After Allergen Challenge, Safety and Tolerability of Inhaled CHF6001 DPI in Asthmatics

Phase: N/A Priority: Normal
NCT ID: NCT01689571 Org: User:
Start: 10/31/12 End: 04/30/13 Due: 04/30/14

Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients

Phase: N/A Priority: Normal
NCT ID: NCT03614234 Org: User:
Start: 11/13/18 End: 03/28/26 Due: 03/28/27

Efficacy Of Clodronate 200 Mg/4 Ml I.M. Solution With 1% Lidocaine Every Other Week Vs Clodronate 100 Mg/3,3ml I.M. Solution With 1% Lidocaine Once-Week In A 1-Year Treatment Period Of Women With Postmenopausal Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT01348243 Org: User:
Start: 10/31/11 End: 03/31/13 Due: 03/31/14

Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01577082 Org: User:
Start: 04/30/12 End: 11/30/12 Due: 11/30/13

Lamazym Aftercare Study

Phase: N/A Priority: Normal
NCT ID: NCT01908725 Org: User:
Start: 06/30/13 End: 09/30/22 Due: 09/30/23

Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients

Phase: N/A Priority: Normal
NCT ID: NCT01908712 Org: User:
Start: 08/31/13 End: 09/30/22 Due: 09/30/23